Anti-VEGF therapy is extensively used in solid malignant tumors [14], [54], [55], and the anti-tumor efficacy of anti-VEGF antibodies has been demonstrated in relapsed HL patients [56]. The gene discussed is VEGFA; the disease is neoplasm.